Syngene International

Syngene International FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Syngene International (SYNGENE.NS) as of Oct 31, 2026 is 193.05 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 80.11 % — a change of 140.99% (higher).

FCF Conversion

193.05 %

YoY

140.99%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Syngene International is 2026 193.05 % . FCF Conversion Rate (FCF/EBITDA) of Syngene International was 2025 80.11 % . It decreases by 140.99% higher compared to the previous year.

The Syngene International FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
14.20 INR
Jan 1, 2020
8.25 INR
Jan 1, 2021
62.90 INR
Jan 1, 2022
26.55 INR
Jan 1, 2023
65.74 INR
Jan 1, 2024
107.86 INR
Jan 1, 2025
80.11 INR
Jan 1, 2026
193.05 INR
The Syngene International FCF Conversion history
YEARFCF ConversionYoY
193.05 %+140.99%
80.11 %-25.73%
107.86 %+64.07%
65.74 %+147.58%
26.55 %-57.79%
62.90 %+662.44%
8.25 %-41.91%
14.20 %-47.42%
27.01 %-14.99%
31.78 %+275.11%
8.47 %-108.00%
-105.94 %-192.84%
114.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syngene International Stock analysis

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngene International stock

FCF Conversion Rate (FCF/EBITDA) of Syngene International is 193.05 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Syngene International changed from 80.11 % to 193.05 %, representing a 140.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Syngene International since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Syngene International with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Syngene International

All Key Metrics — Syngene International